179 related articles for article (PubMed ID: 29956502)
1. Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer.
Coulson-Gilmer C; Humphries MP; Sundara Rajan S; Droop A; Jackson S; Condon A; Cserni G; Jordan LB; Jones LJ; Kanthan R; Di Benedetto A; Mottolese M; Provenzano E; Kulka J; Shaaban AM; Hanby AM; Speirs V
J Pathol Clin Res; 2018 Oct; 4(4):241-249. PubMed ID: 29956502
[TBL] [Abstract][Full Text] [Related]
2. A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC).
Yu XF; Yang HJ; Yu Y; Zou DH; Miao LL
PLoS One; 2015; 10(8):e0136670. PubMed ID: 26313461
[TBL] [Abstract][Full Text] [Related]
3. Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas.
Lin S; Guo Q; Wen J; Li C; Lin J; Cui X; Sang N; Pan J
J Exp Clin Cancer Res; 2014 Mar; 33(1):26. PubMed ID: 24606961
[TBL] [Abstract][Full Text] [Related]
4. Expression of stanniocalcin-1 and stanniocalcin-2 in laryngeal squamous cell carcinoma and correlations with clinical and pathological parameters.
Zhou H; Li YY; Zhang WQ; Lin D; Zhang WM; Dong WD
PLoS One; 2014; 9(4):e95466. PubMed ID: 24743310
[TBL] [Abstract][Full Text] [Related]
5. Expression of Stanniocalcin 2 in Breast Cancer and Its Clinical Significance.
Jiang ST; Wang HQ; Yang TC; Wang DW; Yang LJ; Xi YQ; Kong FZ; Pan XK; Xu LH; Feng MH; Xie W; Su F
Curr Med Sci; 2019 Dec; 39(6):978-983. PubMed ID: 31845230
[TBL] [Abstract][Full Text] [Related]
6. Identification of NTN4, TRA1, and STC2 as prognostic markers in breast cancer in a screen for signal sequence encoding proteins.
Esseghir S; Kennedy A; Seedhar P; Nerurkar A; Poulsom R; Reis-Filho JS; Isacke CM
Clin Cancer Res; 2007 Jun; 13(11):3164-73. PubMed ID: 17545519
[TBL] [Abstract][Full Text] [Related]
7. Stanniocalcin 2 contributes to aggressiveness and is a prognostic marker for oral squamous cell carcinoma.
Ferreira do Carmo A; Dourado MR; Ervolino de Oliveira C; Bastos DC; Domingueti CB; Ribeiro Paranaíba LM; Sawazaki-Calone Í; Borges GÁ; Silva Guerra EN; Casarin RC; Graner E; Salo TA; de Almeida Freitas R; Galvão HC; Coletta RD
Exp Cell Res; 2020 Aug; 393(2):112092. PubMed ID: 32445747
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease.
Jansen MP; Sas L; Sieuwerts AM; Van Cauwenberghe C; Ramirez-Ardila D; Look M; Ruigrok-Ritstier K; Finetti P; Bertucci F; Timmermans MM; van Deurzen CH; Martens JW; Simon I; Roepman P; Linn SC; van Dam P; Kok M; Lardon F; Vermeulen PB; Foekens JA; Dirix L; Berns EM; Van Laere S
Mol Oncol; 2015 Jun; 9(6):1218-33. PubMed ID: 25771305
[TBL] [Abstract][Full Text] [Related]
9. Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients.
Li X; Yang J; Krishnamurti U; Huo L; Ward KC; O'Regan R; Peng L
Clin Breast Cancer; 2017 Aug; 17(5):356-366. PubMed ID: 28576631
[TBL] [Abstract][Full Text] [Related]
10. Stanniocalcin-2 May Be a Potentially Valuable Prognostic Marker in Endometrial Cancer: a Preliminary Study.
Aydin HA; Toptas T; Bozkurt S; Aydin A; Erdogan G; Pestereli E; Simsek T
Pathol Oncol Res; 2019 Apr; 25(2):751-757. PubMed ID: 30661222
[TBL] [Abstract][Full Text] [Related]
11. Men and women show similar survival outcome in stage IV breast cancer.
Wu SG; Zhang WW; Liao XL; Sun JY; Li FY; Su JJ; He ZY
Breast; 2017 Aug; 34():115-121. PubMed ID: 28577471
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of high expression of stanniocalcin-2 in hepatocellular carcinoma.
Wang Y; Wu J; Xu J; Lin S
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30962272
[TBL] [Abstract][Full Text] [Related]
13. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G
Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365
[TBL] [Abstract][Full Text] [Related]
14. A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer.
Humphries MP; Sundara Rajan S; Droop A; Suleman CAB; Carbone C; Nilsson C; Honarpisheh H; Cserni G; Dent J; Fulford L; Jordan LB; Jones JL; Kanthan R; Litwiniuk M; Di Benedetto A; Mottolese M; Provenzano E; Shousha S; Stephens M; Walker RA; Kulka J; Ellis IO; Jeffery M; Thygesen HH; Cappelletti V; Daidone MG; Hedenfalk IA; Fjällskog ML; Melisi D; Stead LF; Shaaban AM; Speirs V
Clin Cancer Res; 2017 May; 23(10):2575-2583. PubMed ID: 27986751
[No Abstract] [Full Text] [Related]
15. Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker.
Johansson I; Nilsson C; Berglund P; Lauss M; Ringnér M; Olsson H; Luts L; Sim E; Thorstensson S; Fjällskog ML; Hedenfalk I
Breast Cancer Res; 2012 Feb; 14(1):R31. PubMed ID: 22333393
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of clinicopathological significance, BIRC7, and STC2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.
Yuan Y; Yang ZL; Zou Q; Li JH; Li DQ; Liang LF; Zeng GX; Chen SL
Neoplasma; 2013; 60(6):698-705. PubMed ID: 23906305
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of mitotic index and Bcl2 expression in male breast cancer.
Lacle MM; van der Pol C; Witkamp A; van der Wall E; van Diest PJ
PLoS One; 2013; 8(4):e60138. PubMed ID: 23573235
[TBL] [Abstract][Full Text] [Related]
18. Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study.
Leone J; Zwenger AO; Leone BA; Vallejo CT; Leone JP
Am J Clin Oncol; 2019 Feb; 42(2):215-220. PubMed ID: 30499840
[TBL] [Abstract][Full Text] [Related]
19. mRNA expression level of estrogen-inducible gene, alpha 1-antichymotrypsin, is a predictor of early tumor recurrence in patients with invasive breast cancers.
Yamamura J; Miyoshi Y; Tamaki Y; Taguchi T; Iwao K; Monden M; Kato K; Noguchi S
Cancer Sci; 2004 Nov; 95(11):887-92. PubMed ID: 15546506
[TBL] [Abstract][Full Text] [Related]
20. Stanniocalcin Expression as a Predictor of Late Breast Cancer Recurrence.
Brantley KD; Kjærsgaard A; Cronin-Fenton D; Yacoub R; Nielsen AS; Lauridsen KL; Hamilton-Dutoit S; Lash TL
Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):653-659. PubMed ID: 29593009
[No Abstract] [Full Text] [Related]
[Next] [New Search]